Searched for
ELI LILLY DIABETES TREATMENT
He was 34, active. No diabetes, no high BP. Doctor reveals one 'harmless habit' which caused 34-year-old to almost die from strokeA 34-year-old man, despite being exceptionally healthy, suffered a stroke due to a seemingly harmless habit: forcefully cracking his neck. ...- Quote of the day by Holocaust survivor Elie Wiesel: 'We must always take sides. Neutrality helps the oppressor, never the victim. Silence encourages the tormentor...' Nobel laureate's award speech on why standing with victims is the right choice, not staying neutralToday's quote comes from Holocaust survivor, author and Nobel Peace Prize laureate Elie Wiesel, who spoke these powerful words during his N...
- Medical device maker Zimmer Biomet to hire 500 employees in 3 years for tech centre in IndiaMedical device giant Zimmer Biomet is set to significantly expand its Indian footprint by hiring 500 professionals over three years for its...
- Shantha Biologics to Make Injectable Drug Cartridges for Novo NordiskShantha Biologics has secured a significant contract with Danish pharmaceutical giant Novo Nordisk to manufacture cartridges for injectable...
- Healthy at 34, but a simple neck-cracking habit led to a stroke: Doctor explains hidden riskA seemingly harmless habit of forcefully cracking one's neck has been linked to a rare but life-threatening stroke in a healthy 34-year-old...
- Bird language decoded: A scientist figured out how birds talk, and got $100,000 for itA US researcher has earned $100,000 for deciphering zebra finch calls, identifying 11 core "words" that convey identity and intent. Dr. Jul...
- 'Cheaper than a gym, but still not selling': Nithin Kamath on why Indians aren't embracing popular weight-loss drugsDespite rising obesity and affordable generic GLP-1 drugs, India lags in adoption. Nithin Kamath highlights patient retention challenges wi...
- My wife and I declared diabetes in our health insurance policy. Will it cover new illnesses too?ET Wealth Reader's Query: My wife and I have had a floater health insurance policy for over four years. We declared diabetes as a pre-exist...
- Why do people snore? Causes, symptoms, risks and how to stop snoringSnoring, often dismissed as a mere annoyance, can signal underlying health issues like sleep apnea. The sound arises from obstructed breath...
- Dow Jones hits record above 52,000 as Alphabet debuts in index, S&P 500 climbs and Nasdaq jumps over 2% as tech stocks lead Wall Street rally - here's how US stock market performed today (June 29)S&P 500, Dow Jones and Nasdaq today June 29: The US stock market started the shortened trading week with solid gains as the Dow Jones close...
- Kiran Mazumdar-Shaw warns against long-term GLP-1 use, urges caution over weight-loss drugs, says 'for those who are not diabetic or clinically obese...'Nithin Kamath questions India's slow adoption of affordable GLP-1 weight-loss drugs, despite rising obesity. He points to challenges like l...
- Centre set to tighten oversight of pharma packaging materialsIndia is set to implement a mandatory registration for printed pharmaceutical packaging manufacturers to combat counterfeit drugs. This mov...
- Eli Lilly launches cancer drug Tanstrive in IndiaThe launch follows marketing authorisation from the Central Drugs Standard Control Organisation (CDSCO) for patients with locally advanced ...
- Kiran Mazumdar-Shaw eyes crown of world’s top insulin supplier for BioconIndian drugmaker Biocon aims to be the world's top insulin supplier within five years, capitalising on growing demand as major pharmaceutic...
- Global drugmakers rush to boost US presence as tariff threat loomsGlobal drug companies are boosting U.S. production and stockpiling medicines. This is a response to potential tariffs on branded drugs. Com...
- Eli Lilly's Alzheimer's drug donanemab approved in India, but neurologists flag cost, access barriersA new drug for Alzheimer's, donanemab, has arrived in India. It aims to slow the disease's progression by clearing brain plaques. While off...
- India's weight-loss drug boom raises questions over healthcare prioritiesIndia's market for cheaper anti-obesity drugs has surged tenfold. While demand is high, especially among those with diabetes, concerns abou...
- UK approves Novo weight-loss pill to edge open European marketBritain's medicine regulator has approved Novo Nordisk's weight-loss pill. This makes the UK the first European market for the oral treatme...
- US stocks: Lilly shares rise on hopes that next-gen drug will extend lead in weight-loss marketLilly presented full data from two retatrutide trials, one in treatment naive type 2 diabetes patients and another in patients with obesity...
- Eli Lilly says next-gen obesity drug curbs sleep apnea, among other benefitsEli Lilly presented trial results for its new obesity drug retatrutide. The drug significantly reduced sleep apnea severity and knee osteoa...
Load More
